MegaPro Biomedical Co., Ltd (6827.TWO)
TWD 10.05
(-17.28%)
TWD 10.05
(-17.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 294.58 Million TWD | -14.04% |
| 2022 | 342.68 Million TWD | -20.79% |
| 2021 | 432.6 Million TWD | 63.16% |
| 2020 | 265.14 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 306.38 Million TWD | 4.01% |
| 2023 FY | 294.58 Million TWD | -14.04% |
| 2023 Q2 | 287.41 Million TWD | -16.13% |
| 2023 Q4 | 294.58 Million TWD | 2.5% |
| 2022 Q4 | 342.68 Million TWD | 0.0% |
| 2022 FY | 342.68 Million TWD | -20.79% |
| 2021 FY | 432.6 Million TWD | 63.16% |
| 2020 FY | 265.14 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -130.057% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 89.845% |
| Level Biotechnology Inc. | 822.67 Million TWD | 64.192% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 55.684% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 46.318% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 92.435% |
| GlycoNex Incorporation | 1.55 Billion TWD | 81.029% |
| VBI | 452.1 Million TWD | 34.842% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 74.954% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 60.648% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 22.143% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 74.019% |
| Visgeneer Inc. | 397.17 Million TWD | 25.831% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 92.187% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 86.356% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 66.642% |
| Neith Corporation | 192.15 Million TWD | -53.305% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 95.165% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -300.474% |
| Enimmune corporation | 604.82 Million TWD | 51.295% |
| TaiRx, Inc. | 833.74 Million TWD | 64.668% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 90.454% |
| EirGenix Inc. | 11.16 Billion TWD | 97.361% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 48.602% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 82.797% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 91.81% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 71.958% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | 2.143% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -11.307% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 33.231% |
| RBC Bioscience Corporation | 753.79 Million TWD | 60.92% |
| BiOptic Inc. | 613.77 Million TWD | 52.005% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 83.438% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 74.599% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 54.318% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 90.517% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -99.13% |
| NaviFUS Corp. | 490.53 Million TWD | 39.947% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 75.967% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 78.393% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 44.329% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 74.635% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 82.214% |
| AP Biosciences Inc | 890.75 Million TWD | 66.929% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 96.545% |
| 3D Global Biotech Inc. | 324.14 Million TWD | 9.121% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 77.912% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 89.134% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 98.083% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 28.196% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 25.77% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 85.81% |
| TCI GENE Inc. | 1.16 Billion TWD | 74.734% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 78.393% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 68.72% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 57.824% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 92.55% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 92.294% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 76.047% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 94.743% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 72.262% |
| Acepodia, Inc. | 6.81 Billion TWD | 95.68% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 92.302% |